Additional Contributor(s) Brinda M
Effect of glucagon-like peptide-1 receptor agonists in patients with psoriasis
Originally developed for Type 2 diabetes, these medications have gained FDA approval for obesity, reducing risk for heart disease and kidney disease, and treatment of obstructive sleep apnea within the last three years
Why Researchers Study These Peptides Together A frequent question from beginners is whether sermorelin, ipamorelin, and tesamorelin are studied in combination, and the answer is yes, precisely because they hit different receptors
Walaupun Hydroquinone diharamkan penggunaannya di banyak negara, namun berbeza dengan Arbutin
Allyl isothiocyanate as a cancer chemopreventive phytochemical